Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies

University Medical Centre Ljubljana

Status: Completed

Conditions: COVID-19; Influenza; ARDS

Study type: Observational

Funder types: Other

Identifiers

NCT05353725

ECMO in ARDS

Details and patient eligibility

About

A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies

Full description

All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics and outcomes were studied according to ARDS ethiology: COVID-19, influenza and other ethiologies.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient with acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO)
• 18 years or older

Exclusion criteria

• Patient not eligible for ECMO treatment per institutional guidelines (terminal illness, palliative care)

Trial design

100 participants in 3 patient groups

COVID-19 ARDS

Description:

Patients with COVID-19 ARDS on veno-venous ECMO (vvECMO)

Influenza ARDS

Description:

Patients with Influenza ARDS on vvECMO

ARDS of Other Ethiologies

Description:

Patients with ARDS of Other Ethiologies on vvECMO